OR WAIT null SECS
Cambridge Major Laboratories and AAIPharma Services plan to merge to form a global supplier of integrated CMC services.
, a CMO providing pharmaceutical API development and manufacturing, and AAIPharma Services, a provider of pharmaceutical analytical testing, product development, and manufacturing services, have announced their intent to merge to form a global supplier of integrated chemistry, manufacturing, and control (CMC) services. Financial terms of the merger were not disclosed. The merger is expected to close by the end of October 2013, subject to Hart-Scott-Rodino approval and other closing conditions.
Source: Cambridge Major Laboratories